Orbis S.A.:戦略・SWOT・企業財務分析

◆英語タイトル:Orbis S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014574
◆発行会社(調査会社):MarketLine
◆発行日:2017年11月12日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Orbis S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Orbis S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Orbis S.A. (Orbis) is a tourism and hotel group based in Poland. The company’s major facilities consist of suites and rooms, health and fitness centers, restaurants and bars, and cafes. It also offers tennis courts, horse riding, swimming pools, boat cruises, golf courses, and conference and meeting rooms. Orbis operates its hotels under the brands of Pullman, M Gallery, ibis, ibis Styles, ibis budget Sofitel, Novotel and Mercure . The company’s portfolio includes owned hotels, leased hotel, hotels under management agreements and franchised properties across Poland and Lithuania. The company operates its hotels in collaboration with Accor Hotels and under Accor brands including Ibis, Ibis budget, Novotel, Mercure, Sofitel, and ibis Styles. Orbis is headquartered in Warsaw, Poland.

Scope

- Detailed information on Orbis S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Orbis S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Orbis S.A. including a breakdown and examination of key business segments
- Intelligence on Orbis S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Orbis S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Orbis S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Orbis S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Orbis S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Orbis S.A.: Company Overview
Orbis S.A.: Overview and Key Facts
Orbis S.A.: Overview
Orbis S.A.: Key Facts
Orbis S.A.: Key Employees
Orbis S.A.: Key Employee Biographies
Orbis S.A.: Major Products and Services
Orbis S.A.: Company History
Orbis S.A.: Locations and Subsidiaries
Orbis S.A.: Key Competitors
Orbis S.A.: Company Analysis
Orbis S.A.: Business Description
Orbis S.A.: SWOT Analysis
Orbis S.A.: SWOT Overview
Orbis S.A.: Strengths
Orbis S.A.: Weaknesses
Orbis S.A.: Opportunities
Orbis S.A.: Threats
Orbis S.A.: Corporate Financial Deals Activity
Orbis S.A.: Financial Deals Overview
Orbis S.A.: Top Deals 2013 – 2017YTD*
Orbis S.A.: Divestments
Orbis S.A.: Recent Developments
Orbis S.A.: News and Events Summary
Orbis S.A.: Business Expansion
Orbis S.A.: Corporate Governance
Orbis S.A.: Financial Deals
Orbis S.A.: Financial Performance
Orbis S.A.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Orbis S.A.: Key Facts
Table 2: Orbis S.A.: Key Employees
Table 3: Orbis S.A.: Locations and Subsidiaries
Table 4: Orbis S.A.: Key Competitors
Table 5: Orbis S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Orbis S.A.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Orbis S.A.: Top Deals 2013 - 2017YTD*
Table 8: Orbis S.A.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 9: Orbis S.A.: News and Events Summary
Table 10: Orbis S.A.: Business Expansion
Table 11: Orbis S.A.: Corporate Governance
Table 12: Orbis S.A.: Financial Deals
Table 13: Orbis S.A.: Financial Performance
Table 14: Orbis S.A.: Strategy and Operations

★海外企業調査レポート[Orbis S.A.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • B. Braun Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary B. Braun Medical Inc (B. Braun), a subsidiary of B. Braun Melsungen AG, is a medical device company that provides infusion therapy and pain management technology, products and services. The company’s product portfolio includes TPN compounding bags, parenteral nutrition additives, closed syst …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chesapeake Energy Corporation:企業の戦略・SWOT・財務情報
    Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Chesapeake Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • eBay Inc:企業のM&A・事業提携・投資動向
    eBay Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's eBay Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Powszechny Zaklad Ubezpieczen Group:企業の戦略・SWOT・財務情報
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Trafigura Group Pte Ltd:企業の戦略的SWOT分析
    Trafigura Group Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Apple Inc:企業のM&A・事業提携・投資動向
    Apple Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apple Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Daewoong Pharmaceutical Co Ltd (069620) – Product Pipeline Analysis, 2018 Uate
    Summary Daewoong Pharmaceutical Co Ltd (Daewoong Pharma) is one of the leading manufacturers and distributors of prescription drugs in South Korea. It offers prescription drugs, quasi drugs, medical devices, cosmetics, health foods and APIs. The company produces products in the forms of tablets, cap …
  • G Adventures Inc:企業の戦略・SWOT・財務情報
    G Adventures Inc - Strategy, SWOT and Corporate Finance Report Summary G Adventures Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • PanOptica Inc-製薬・医療分野:企業M&A・提携分析
    Summary PanOptica Inc (PanOptica) is a biopharmaceutical company that develops new ocular therapies in the field of ophthalmology. The company concentrates on candidates that are at or near the investigational new drug application stage. It licenses and develops novel therapeutics that can improve e …
  • Chennai Meenakshi Multispeciality Hospital Ltd (523489):企業の財務・戦略的SWOT分析
    Chennai Meenakshi Multispeciality Hospital Ltd (523489) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • Centers for Disease Control and Prevention-医療機器分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Helix BioPharma Corp (HBP)-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cance …
  • Traverse Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an privately held bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company provides lead candidate TRB-N0224 which is dev …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • Portigon Ag:企業の戦略・SWOT・財務分析
    Portigon Ag - Strategy, SWOT and Corporate Finance Report Summary Portigon Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Active Motif Inc:医療機器:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company's product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy …
  • EyePoint Pharmaceuticals Inc (PSDV):製薬・医療:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • iVascular SLU:企業の製品パイプライン分析2018
    Summary iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆